Lataa...
Randomized Controlled Trial of Two Dosing Schedules for Human Papillomavirus Vaccination among College Age Males
BACKGROUND: Quadrivalent human papillomavirus (HPV) vaccine, for protection against sexually transmitted HPV infection, is licensed for females and males 9–26 years on a 3-dose schedule (0, 2, and 6 months; Standard schedule). Vaccine uptake has been low and catch-up vaccination of older adolescents...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4048919/ https://ncbi.nlm.nih.gov/pubmed/24342252 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2013.11.098 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|